We examined whether 7-nitroindazole (7-NI), a putative inhibitor of neuronal nitric oxide synthase (nNOS), decreases cerebral infarction 24 h after proximal middle cerebral artery (MCA) occlusion. In preliminary experiments, we determined that 7-NI (25, 50, and 100 mg/kg i.p.) decreased nitric oxide synthase (NOS) activ ity within cerebral cortex by 40-60% when measured up to 120 min, but not 240 min after administration. At 25 or 50 mg/kg, 7-NI did not alter the systemic arterial blood pressure or the dilation of pial arterioles after topical ace tylcholine (10 and 100 j-LM). To examine the effect of 7-NI on infarct size, 55 Sprague-Dawley halothane anesthetized rats were subjected to proximal MCA occlu sion (modified Tamura method). Five minutes after oc clusion, 7-NI (25 or 50 mg/kg i.p.) or vehicle was injected. Animals treated with 25 or 50 mg/kg showed 25 and 27%
Nitric oxide (NO) has been implicated in isch emic pathophysiology both as a mediator of neuro toxicity and as a neuroprotective agent (for review see Dawson et ai., 1992; Moncada and Higgs, 1993) . NO is synthesized by neurons and endothelium (Palmer et ai., 1988; Knowles et ai., 1989; Moncada et ai., 1989) and causes toxicity in part, after con version to peroxynitrite and oxygen radicals (Beck man et ai., 1990; Radi et ai., 1991) . In neuronal reductions in infarct volume, respectively. Coadministra tion of L-arginine (300 mg/kg i.p,) plus 7-NI (25 mg/kg i.p.) reversed the effect. If, indeed, the effects of 7-NI are mediated by inhibition of nNOS activity, these results suggest that enzymatic products of the neuronal isoform promote ischemic injury and that they do so at least within the first few hours after permanent occlusion. The results also emphasize the importance of developing strategies to selectively inhibit the neuronal isoform inas much as we observed previously that administering the less selective NOS inhibitor, N"'-nitro-L-arginine (L-NA), in the same model either caused no change or increased the volume of ischemic injury. Key Words: Acetylcho line-Focal cerebral ischemia-Neuronal nitric oxide synthase-Nitric oxide-7-Nitroindazole.
cultures, inhibition of NO synthesis affords protec tion against glutamate-mediated neurotoxicity (Dawson et ai., 1991; Corasaniti et ai., 1992) . In animal models of focal cerebral ischemia, inhibition of NO synthesis reduces infarction volume and ischemic injury when tested in mice, cats, and rats (Nowicki et al., 1991; Buisson et al., 1992; Nishikawa et ai., 1993) .
Not all studies agree. We (Morikawa et ai., 1994 ) and others (Yamamoto et ai., 1992; Kuluz et ai., 1993) reported that N"'-nitro-L-arginine (L-NA) in creased infarction size following middle cerebral ar tery (MCA) occlusion (MCAO) in spontaneously hypertensive rats (SHR) or Wister rats. Moreover, the precursor of NO, L-arginine (300 mg/kg), de creased infarction volume when administered shortly after MCAO by a blood flow-dependent mechanism (Morikawa et ai., 1992a,b; Moskowitz et ai., 1993) . So when regional CBP (rCBP) in creased above 30% within the penumbral zone after L-arginine, there was a concomitant restoration of the electrocorticogram (ECoG) that followed within minutes after starting the infusion. ECoG recovery never anticipated the rCBF change (Dalkara et al., 1994) . Inhibitors of NO synthase (NOS) such as L-NAME blocked L-arginine-induced increases in pial vessel caliber and rCBF, and L-arginine's ef fect was enantiomer specific (Morikawa et al., 1992a) . More recently, Zhang and Iadecola (1993) reported that an NO donor, sodium nitroprusside (2.5 mg/kg, intraarterially), decreased infarct vol ume in cortex by 76%.
We suggested that selective inhibition of the neu ronal isoform might clarify the role of NO in isch emic pathophysiology in vivo. We therefore tested the effects of 7-nitroindazole (7-NI) , a compound that inhibits neuronal NOS (nNOS) activity in vivo, on infarction size in the same model in which we reported previously that L-NA or L-NAME showed no protective effect (Morikawa et al., 1994, unpub lished data) .
MATERIALS AND METHODS
Materials 7-NI (Cookson Chemical Ltd., Southampton, UK) was dissolved in peanut oil(10 mllkg; Sigma Chemical Co, St. Louis, MO, U.S.A.). L-Arginine (Sigma) was dissolved in normal saline (300 mg/mi). 2,3,5-Triphenyltetrazolium chloride monohydrate (TTC) was supplied by Sigma.
NOS assay
To determine the effects of 7-NI on brain NOS, NOS activity was measured within forebrain 30 min and I, 2, and 4 h after injection of either 25, 50, or 100 mg/kg i.p. Brains were frozen ( -70°C) until assay.
NOS activity was measured by the conversion of [3H]arginine to [3H]citrulline according to the method de scribed by Bredt and Snyder (1989) . After weighing, sam ples were homogenized in cold HEPES buffer (50 mM, 500 I.d) containing I mM EDTA (pH 7.4). Homogenates were centrifuged (2,500 rpm, 5 min, 4°C) and the super natant was used for assay. The incubation mixture con tained 100 fLl of HEPES (50 mM), EDTA (1 mM), �-nic otinamide adenine dinucleotide phosphate reduced form 
General surgical p r ocedures
Male Sprague-Dawley rats (280-330 g; Charles River Laboratories, Wilmington, MA, U.S.A.) were housed un der diurnal lighting conditions and given access to food and water ad libitum. Anesthesia was induced with 2% halothane in a gas mixture of 30% 02170% N20 and main tained at 0.7-1%. An endotracheal tube was inserted and animals were connected to a mechanical ventilator (7025; UGO BASILE, Varese, Italy). Atropine sulfate (0.15 mg/ kg i.m.) and cephazolin (50 mg/kg Lm.) were given im mediately after the induction of anesthesia. Arterial blood pressure was monitored (RS3200; Gould, Rutherford, NJ, U.S.A.) via the right femoral artery and recorded for up to 45 minutes after MCAO. Blood gases were obtained from arterial samples taken from the right femoral artery (Corning 178 blood gas/pH analyzer; Ciba Corning Diag nostics, Medford, MA, U.S.A.) at the time of MCAO and 45 min later. Hematocrit and blood glucose levels were also monitored.
The right MCA was occluded by a modification of the Tamura method as described previously (Tamura et aI., 1981; Bederson et aI., 1986a; Morikawa et aI., 1992b) . Briefly, a horizontal incision was made between the right outer canthus and the anterior pinna. The zygoma was removed and the temporalis muscle dissected and re tracted to expose the infratemporal fossa. Through a small craniectomy performed with a saline-cooled dental drill, the MCA was ligated with a 10-0 nylon suture im mediately proximal to the origin of the lenticulostriate artery. After ligation, the vessel was cauterized (Model 440E; Radionics, Burlington, MA, U.S.A.) to the rhinal fissure and then transected. Anesthesia was maintained for an additional 45 min and arterial blood pressure, body temperature, and endotidal CO2 (Multinex 4300; Data scope, Paramus, NJ, U.S.A.) monitored continuously. Body temperature was kept at 37°C by a Homeothermic Blanket Control Unit (Harvard Apparatus, Natick, MA, U.S.A.). On recovering from anesthesia, all animals were returned to their cages and allowed free access to water and soft food until sacrifice.
Infarction size
Animals were killed by decapitation, and their brains removed quickly, placed in ice-cold saline for 10 min, and cut into 7 x 2-mm coronal slices in a rodent brain matrix (RBM4000C; Activational Systems Inc.). Sections were stained with TTC (2%; Sigma) as described previously (Bederson et aI., 1986b; Kano et aI., 1991) . Infarction area was measured using a Bioquant IV image analysis system. The volume of infarction was calculated by nu meric integration of data from individual slices.
Closed cranial window preparation
Sprague-Dawley rats (330 g) were initially anesthetized with 2% halothane in a gas mixture containing 02/N20 (30170%) and maintained with a-chloralose (50 mg/kg i.p.) and urethane (750 mg/kg Lp.). The femoral artery and endotracheal tubing were placed for blood pressure mon itoring and mechanical ventilation. After general prepa ration, the head was fixed in a stereotaxic frame, after which the left parietal bone was exposed by a longitudinal midline skin incision and the temporal muscle removed. Dental acrylic was applied to the intact calvarium. Two polyethylene tubes were embedded in the dental acrylic for superfusion. A craniectomy (6 mm in diameter) was created in the center of a dental acrylic doughnut using a power drill while cooling with saline. After reflecting the dura mater along with the closed attached arachnoidal membrane, the exposed pial surface was continuously su perfused with artificial cerebrospinal fluid (CSF) main tained at 37°C (M3 Lauda type B; Koenigstrofen, Ger many) and sealed immediately with a cover glass 12 mm in diameter using cyanoacrylate as described by Morii et al. (1986) . The volume under the window was 0.8 ml. Intracranial pressure was maintained at 5-8 mm Hg by adjusting the outlet tube to an appropriate height. Pial vessels were visualized at a 200 x magnification using an intravital microscope (Leitz, Germany) with xenon illu mination equipped with heat and green light fibers. Se lected pial arterioles (one or two per animal) were then imaged using a videocamera onto a high-resolution black and-white monitor (series CCD-72 System; Dage MTI, Michigan City, IN, U.S.A.), and the vessel diameter was measured at selected points with an automated video width analyzer (Model C3l61; Hamamatsu Photonics, Hamamatsu, Japan).
Protocols
Pial vessel response. To examine the effect of 7-NI (50 mg/kg i.p.) on the endothelium-mediated vasodilation, we measured the change in caliber of pial arterioles to topical acetylcholine (10 and 100 fLM) before and 1 h after 7-NI administration.
Infarct size. To examine the effect on infarct volume, 7-NI [25 mg/kg (n = 9), 50 mg/kg (n = 8); 1 ml/kg i.p.] or vehicle (n = 13) was injected 5 min after MCAO. Forty five minutes later, anesthesia was discontinued and the animals were returned to their cages until sacrifice at 24 h.
To test the ability of L-arginine to reverse the effects of 7-NI, 7-NI [25 mg/kg i.p. (n = 8)] was administered alone or with L-arginine [300 mg/kg i.p. (n = 8)] 5 min after MCAO. The animals were again monitored for 45 min, after which they were returned to their cages until sacri fice at 24 h.
Statistical analysis
Physiological parameters were compared between groups by repeated-measures analysis of variance fol-lowed by Fischer's least significant difference test. Dif ferences in infarct areas and volumes were analyzed by Student's t test using the statistical software Stat View 4.0 and Superanova 1-11 (Abacus Concepts, Inc., Berke ley, CA, U.S.A.). Differences were considered signifi cant at p < 0.05. Data are expressed as mean ± SD. Table 1 shows that the MABP did not change after 7-NI treatment when determined every 15 min for up to 45 min after MCAO. There were no sig nificant differences in blood gases, blood glucose, hematocrit, and rectal temperature between control and drug-treated rats either before or after MCAO.
RESULTS
NOS activity after 7-NI treatment 7-NI administered at 25, 50, or 100 mg/kg de creased NOS activity within the forebrain, whereas vehicle was inactive. NOS activity was reduced by approximately 50% after 30 min and remained de creased for up to 120 min (Table 2) . By 4 h, NOS activity did not differ from baseline. 7-NI, 100 mg/ kg, did not inhibit enzyme activity further when tested after 60 min.
Proximal MCAO caused an infarct that affected both the cortex and the striatum. 7-NI significantly decreased the total volume of infarction, by 25 and 27 %, when injected at 25 or 50 mg/kg, respectively (Table 3 ). The reduction was evident in both cortex and striatum. Infarction areas for the seven coronal sections are presented in Fig. 1 . Statistically signif icant decreases were detected in sections 3-5. Coadministration of 7 -NI and L-arginine reversed the effects of 7-NI. In the 7-NI group (25 mg/kg), the infarct volume was 211 ± 42 (N = 8), compared to 264 ± 49 (N = 9) in the vehicle group (p < 0.05). After treatment with 7-NI plus L-arginine, the in farct volume was 260 ± 36 (n = 8).
Topical acetylcholine
Baseline pial vessel diameter was 38 ± 3 flm and did not change 60 min after the administration of 7-NI (38 ± 3 flm). There were no statistically sig nificant differences in the acetylcholine responses in the 7-NI-treated animals between the two doses tested (Fig. 2; N = 4) . NOS activity within the cortex beneath the cranial window was 51 ± 9% of the control as measured in vitro at the experiment's end.
DISCUSSION
A major finding in this report is that 7-NI reduced infarction volume by approximately 25% at 24 h after MCAO. Although modest in size, these de creases are reproduc. ible, statistically significant, and accompanied by 50% inhibition of brain NOS activity. The results support the pathophysiological significance of NO in permanent focal ischemia, es pecially within the first few hours after vessel oc clusion. The relatively short duration of drug action «4 h) (compared to L-NA or L-NAME) would mit igate against the potential clinical importance of nNOS inhibition and possibly as a mechanism for 7-NI's neuroprotection in this model. Whether greater protection can be achieved by more pro- (Tamura) in halothane-anesthetized Sprague-Dawley rats as compared with vehicle (circles). Artificially ventilated animals were in jected with 7-NI 5 min after vessel occlusion and sacrificed after 24 h (see Materials and Methods). Infarct area was de termined in TTC-stained coronal sections (2 mm) from ante rior to posterior (sections 1-7, respectively). 'p < 0.05 com pared with vehicle control found and more prolonged nNOS inhibition merits further study.
7-NI and related substituted indazoles are potent and competitive inhibitors of rat brain NOS in vitro and in vivo (Babbedge et aI., 1993; Moore et aI., 1993a,b) . Moore et al. noted that 7-NI decreased NOS activity by approximately 30-40% within mouse cerebellum, cerebral cortex, and hippocam pus when administered at 10 mg/kg i.p. Babbedge et al. reported an ICso of 0.9 ± 0.1 flM when 7-NI was added to rat cerebellar NOS in vitro. Unlike L-NA or L-NAME (for review see Moncada et aI., 1991) , large doses of 7-NI did not raise arterial blood pres sure, block endothelium-dependent relaxation, or inhibit the vasodepressor effect of acetylcholine. Hence, specificity for the neuronal isoform was strongly suggested based on in vivo evidence. How ever, the mechanism that accounts for the apparent selectivity is complex and not well understood. Is sues of compartmentation or metabolism may be relevant because 7-NI potently inhibits bovine en dothelial NOS activity when added in vitro (Babbedge et ai., 1993) .
Our data agree with these findings. Systemic ar terial hypertension was not observed after 50 mg/kg (Table 1 ) and, in several experiments, after 100 mg/ kg i.p. (data not shown). Moreover, systemic 7-NI administration did not diminish the dilator response to topical acetylcholine at a time when brain NOS activity was reduced by 50%. In contrast, L-NA potently blocked acetylcholine-induced relaxation of pial vessels when administered topically (Wei et ai., 1992) .
The fact that a selective nNOS inhibitor de creased infarction size implies a role for neuronal NO in ischemic injury that we and others could not demonstrate using either L-NA or L-NAME (Ya mamoto et ai., 1992; Buisson et al., 1993; Kuluz et al., 1993; Morikawa et ai., 1994) . In our laboratory, three experienced investigators, using both the Tamura and the Brint models of focal ischemia in rats (unpublished data; Morikawa et ai., ]994), failed to obtain evidence that L-NA or L-NAME decreased infarction size after MCAO. Halothane was the anesthetic for both 7-NI and L-NA/L NAME experiments and the dosage and regimen for L-NA or L-NAME reportedly gave protection in published models of focal ischemia in vivo (Buisson et ai., 1993; Nagafuji et ai., 1992) . Both 7-NI and the nonselective inhibitors produced subtotal NOS in hibition in brain. However, NOS inhibition after 7-NI is relatively short-lived compared to L-NA and L-NAME (Dwyer et ai., 1991) .
We postulate that changes in vascular hemody namics (for review see Knowles and Moncada, 1992) , platelets (Radomski et ai., 1987) , and leuko cytes caused by L-NA and L-NAME obscured the consequences of nNOS inhibition and increased in farct size in our models. The reduction in infarct volume after L-arginine infusion or 7-NI in these same models supports this conclusion. It appears that the vascular effects of L-NA/L-NAME may predominate over the neuronal neuroprotective ac tions depending upon the animal model, species, and subtle but important differences in protocols between laboratories, which remain to be defined.
The reversal of 7-NI' s effect on infarct size by L-arginine seems unexpected based on published re ports showing that L-arginine increases rCBF and decreases focal infarct size after MCAO (Morikawa J Cereb Blood Flow Me/ab, Vol. 14, No.6, 1994 et ai., 1992a,b). We do not have an explanation for this response inasmuch as 7-NI does not appear to inhibit endothelial NOS activity in vivo. Perhaps, 7-NI reduced L-arginine uptake into endothelial cells or facilitated L-arginine' s transport into brain. However, there is no experimental evidence that supports these suggestions and additional work will be needed to clarify this point.
7-NI and substituted indazoles may become use ful tools to probe the functions of nNOS and NO during cerebral ischemia. The present report may help to clarify some of the apparent conflicts in the literature regarding the role of NO in ischemic pathophysiology.
